South Korean research institution develops lung cancer breath test with 95% accuracy
It uses a machine with 70 sensors to detect volatile organic compounds associated with the disease
Health & Science
Medical and Pharmaceutical
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
Page 9
NRx Pharmaceuticals submits NDA for intravenous ketamine drug
This therapeutic is specifically designed for suicidal depression
Chicago woman's shock lung cancer diagnosis inspires her to spread awareness
Thankfully, early detection and treatment measures are bringing hope to people who receive the unfortunate news
Is Cardiff Oncology 15% bump due to positive clinical trials or a short squeeze?
Individual biotech stocks often decouple from macro trends when company developments or investor enthusiasm take center stage
Indiana's 'Fight for Air Climb' raises over US$210K to combat lung diseases
More than 480 residents participated in the American Lung Association's annual event
Checkpoint Therapeutics gets picked up by Sun Pharma, enjoys 60% share bump
The deal could provide shareholders with an extra $0.70 per share if company's drug gains regulatory approval in Europe
Hawaii's new Advanced Lung Institute will cut surgery wait time from 8 weeks to hours
It features the state's first AI-powered lung nodule detection program
Indiana's first lung cancer screening truck hits the road
"A truly MONUMENTAL day," said a representative from the IU Simon Comprehensive Cancer Center
Nuvation Bio scoops US$250M financing to launch promising lung cancer therapeutic
Taletrectinib is the most advanced drug in the company's pipeline
TG Therapeutics stock spikes on strong financials and optimism for its flagship drug
The company's product for relapsing forms of multiple sclerosis (RMS), is its primary source of its most recent success
Medtronic explores global options to escape Trump tariffs
Trump imposed 25 per cent duties on imports from Mexico and Canada, set to take effect in March
Poor people die of cancer more than rich: UK research
Nearly half of the 28,400 additional cancer deaths linked to deprivation are due to lung cancer
Pulmonx Corporation shares spike on record-breaking Q4 revenue
Pulmonx achieved USD$83.8 million in worldwide revenue, reflecting a robust 22 per cent growth over 2023
New Korean cancer tech finds mutations with only a few drops of blood
In a clinical trial with blood from 83 patients, the test identified 100 per cent of EGFR gene mutations
Early lung cancer diagnosis saves 52‑year‑old Indian man's life
A persistent cough and breathlessness while climbing stairs prompted him to visit the hospital
PEI needs to jump on lung cancer screening bandwagon ASAP, advocate says
It is the last Canadian province without a program for catching the disease
British scientists develop lung cancer blood test that gives results in 40 minutes
This new screening device is the product of a 3-year study from Cranfield University scholars
Lipella Pharmaceuticals skyrockets on FDA access approval for mouth disease treatment
The stock was up by about 200% during early trading hours
Obesity reduces risk of dying from lung cancer by 21%, South Korean study finds
The investigators examined data from more than 7,000 patients over an 11-year period to make this determination
FDA gives Zai Lab's small cell lung cancer therapeutic orphan drug designation
About 372,000 people are diagnosed with SCLC annually worldwide
Deep learning AI model proves itself useful for CT imaging tumour analysis
It was trained by examining over 1,500 CT scans
bioAffinity Technologies secures Australian patent for 'CyPath Lung' spit test
It will be issued within 3 months provided that there are no opposition filings made by third parties
University of Waterloo and Princess Margaret Cancer Centre collaborate on innovative cancer research
The Canadian Cancer Society reports that healthcare professionals diagnose over 100 types of cancer-related diseases each year
Innovent and ASK Pharm scoop Chinese regulator approval for oral lung cancer drug
'Limertinib' targets non-small cell lung cancer with a particular mutation that is prevalent in Asian patients
Baird Medical rubs shoulders with investors at prestigious healthcare event, sees 77% spike
The annual J.P. Morgan Healthcare Conference is held in San Francisco
South Korean researchers come up with novel treatment option for lung cancer
Non-small cell lung cancer constitutes 85 per cent of all lung cancer cases
Phio Pharmaceuticals skyrockets on skin cancer drug trial success
Shareholders are having a pretty stellar Monday with the immense gains
'ORACLE' lung cancer test helps predict survival with superior precision
British researchers just published an extensive study on the tissue biopsy in Nature Cancer
Sana Biotechnology could offer relief to diabetes type 1 sufferers in the future
The study showed that Sana's hypoimmune (HIP) modified pancreatic islet cells could successfully evade the patient's immune system
Scottish study finds biomarker blood biopsy testing can reduce lung cancer fatalities by 40%
It was completed by the University of St Andrews and published in the PLOS One journal on Wednesday
SILO Pharma flies high on impending patent for intranasal PTSD drug
The stock rose by 146% in early morning trading on the Nasdaq
Hoth Therapeutics up over 218% on dermatology breakthrough for cancer patients
The biopharma operator's 'HT-001" drug was highly successful in alleviating skin issues caused by a cancer treatment
Roche secures rights to Chinese biotech company's small cell lung cancer drug
Innovent Biologics will receive up to US$1 billion in milestone payments and royalties
Russia develops mRNA cancer vaccine for citizens, skepticism lingers
An absence of data has rendered the announcement questionable
The Best of 2024: A Mugglehead roundup
The year’s economic landscape as 2024 comes to a close demonstrates the resilience and adaptability of key sectors
RAPT Therapeutics sees 113% spike on allergy med licensing deal & private placement
The biotech operator can develop and commercialize Jemincare's food allergy medication throughout most of the world
Krystal Biotech reports success with inhalable lung cancer drug in early-stage trial
KB707 demonstrated a 27% objective response rate and 73% disease control rate
Scientists develop scan technique to light up aggressive lung cancer 'like a Christmas tree'
More treatment innovation just in time for the holidays
Portage Biotech soars after initiating proceedings for iOx Therapeutics sale
The stock went up by over 185% after the LOI was announced
Sagimet Biosciences up 30% on strong clinical stage data
Denifanstat received FDA Breakthrough Therapy designation for metabolic dysfunction-associated steatohepatitis